Dummer, R., Robert, C., Chapman, P., Sosman, J., Middleton, M., Bastholt, L., . . . Kirkwood, J. (2008). AZD6244 (ARRY-142886) vs temozolomide (TMZ) in patients (pts) with advanced melanoma: An open-label, randomized, multicenter, phase II study.
Chicago-čujuhus (17. p.)Dummer, R., et al. AZD6244 (ARRY-142886) Vs Temozolomide (TMZ) in Patients (pts) with Advanced Melanoma: An Open-label, Randomized, Multicenter, Phase II Study. 2008.
MLA-čujuhus (9. p.)Dummer, R., et al. AZD6244 (ARRY-142886) Vs Temozolomide (TMZ) in Patients (pts) with Advanced Melanoma: An Open-label, Randomized, Multicenter, Phase II Study. 2008.
Muitte dárkkistit čujuhemiid riektatvuođa, ovdal go geavahat daid iežat deavsttas.